Product Reports Resources Pricing Login Book a demo

Oivi

Biotech & Life Sciences · Oslo, Norway · Founded 2017

Preventing blindness among diabetes patients by deploying an AI-camera for automated diagnosis of retinal diseases MoreLess

Developer of an online platform designed for tracking eye diseases through teleconsultation. The company's platform uses a camera for retinal screening with automated image capture and diagnostics to detect diabetes-related eye diseases, enabling patients to prevent permanent eye blindness. Keywords: Healthcare Devices, Services, Supplies, Blindness Treatment, Camera Platform, Diabetes-Related Blindness, Eye Disease Treatment, Eye Hospital, Eye Treatment.

Talent graph

Oivi's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on Oivi's cap table

Sourced from Dealroom's funding and investor records.

Seed 7 investors entered at this stage
Research Council of Norway
Innovation Norway
European Innovation Council
Arali Ventures
Farvatn Venture
Stratel
Planet 9 Capital

Global footprint

Where Oivi has talent and traffic

Workforce by country
1 countries with
team presence
🇳🇴 Norway15.9%
1 country shown

Market sentiment

What the market is saying about Oivi

An AI-synthesized read of the highest-engagement posts about Oivi on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Oivi on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.